NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-015-2000-0-US-07 ANTIPROGESTINS WITH PARTIAL AGONIST ACTIVITY US National Stage 10/239,548 Abandoned
NCI E-013-2001-0-EP-05 NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME EP National Stage 02773539.8 Abandoned
NCI E-326-2002-0-US-01 Triplex Hairpin Ribozyme US 60/412,930 Abandoned
NIAID E-260-2002-0-US-01 METHODS FOR ASSESSING THE ABILITY OF HIV PATIENTS TO RESTRICT HIV REPLICATION US 60/412,020 Abandoned
NEI E-220-2001-0-HK-38 Nutritional Supplement to Treat Macular Degeneration HK DIV 5108233.5 Expired
NIDCD E-168-2001-0-AU-05 Transduction-1 And Transductin-2 And Applications to Hereditary Deafness AU National Stage 2002326957 Abandoned
NIDCD E-168-2001-0-PCT-02 Transductin-1 And Transductin-2 And Applications to Hereditary Deafness PCT PCT PCT/US02/29614 Expired
NIMH E-014-1997-0-US-06 CHROMOSOMAL MARKERS AND DIAGNOSTIC TESTS FOR MANIC-DEPRESSIVE ILLNESS US DIV 10/251,598 Abandoned
NIDCD E-168-2001-0-EP-06 Transductin-1 And Transductin-2 And Applications to Hereditary Deafness EP National Stage 02761716.6 Abandoned
NIAID E-130-2002-0-US-01 P. ARIASI POLYPEPTIDES AND P. PERNICIOSUS POLYPEPTIDES METHOD OF USE US 60/412,327 Abandoned
NIDCD E-168-2001-0-CA-04 Transduction-1 And Transductin-2 And Applications to Hereditary Deafness CA National Stage 2461065 Abandoned
NCI E-165-2001-0-PCT-02 Maxp1 PCT PCT PCT/US02/29643 Abandoned
NIAID E-092-2002-0-US-01 Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) From cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens. US 60/412,053 Abandoned
NIAID E-263-1999-0-US-03 METHODS OF TREATING INFLAMMATORY BOWEL DISEASE USING CHOLERA TOXIN B SUBUNIT US National Stage 10/129,907 7041296 Expired PDF
NHLBI E-164-2002-0-US-01 MRI NAVIGATOR METHODS AND SYSTEMS US ORD 10/244,903 7561909 Expired PDF
NIAID E-055-1999-0-US-02 Identification and use of High Efficacy Vaccine Antigens Which Modulate Antigen Presenting Cells vbbb US CON 10/246,086 Abandoned
NHLBI E-269-2001-0-EP-04 Endotracheal Tube Using Leak Hole To Lower Dead Space EP National Stage 02773398.9 Abandoned
CC E-308-2002-0-US-01 Inhaled Nitric Oxide Therapy Eliminates the Detrimental Vasoconstrictive Effects of Intravascular Cell-Free Hemoglobin... US 60/411,289 Abandoned
NCI E-110-2003-0-US-01 Anti-CD30 Stalk And Anti-CD30 Antibodies Suitable For Use In Immunotoxins US 60/411,032 Abandoned
NHLBI E-269-2001-0-CA-03 Endotracheal Tube Using Leak Hole To Lower Dead Space CA National Stage 2463538 Abandoned
NHLBI E-269-2001-0-PCT-02 Endotracheal Tube Using Leak Hole To Lower Dead Space PCT PCT PCT/US02/029319 Expired
NIDA E-251-2002-0-US-01 Structurally Rigid Dopamine D3 Receptor Selective Ligands as Cocaine and Methamphetamine Abuse Therapeutics US 60/410,715 Abandoned
NIDCR E-308-2003-0-US-01 Method of Diagnosing and Treating Hyperproliferative Disorders US 60/410,778 Abandoned
NICHD E-209-2001-2-PCT-01 Neurotrophic Components of The ADNF 1 Complex PCT PCT COMB PCT/US02/29146 Abandoned
NCI E-320-2005-0-US-01 Transduced Neoplastic Cell Preparations Able To Express T-cell Costimulatory Molecules B7.1, ICAM-1, And LFA-3 And Induce Immunostimulatory Prophlactic And Therapeutic Anti-tumor Effects In-vivo US 60/410,161 Abandoned
NCI E-082-2004-1-US-01 Methods Of Preventing Or Treating T Cell Malignancies By Adminstering CD2 Antagonists US 60/410,385 Abandoned
NIAID E-286-2002-0-US-01 Aerosolized Capreomycin for Inhibition of Pulmonary Tuberculosis US 60/410,601 Abandoned
NHLBI E-223-2002-0-US-01 FACTORS THAT BIND INTESTNAL TOXINS US 60/409,742 Abandoned
NEI E-304-2003-0-US-01 CONTAINER FOR DRYING BIOLOGICAL SAMPLES, METHODS OF MAKING SUCH CONTAINER, AND METHOD OF USING SAME. US ORD 10/238,147 Abandoned
NIAAA E-041-2000-0-US-04 METHODS AND COMPOUNDS FOR INHIBITING CALPAINS US CON 10/238,978 Abandoned
NCI E-275-2002-0-US-01 Immunotherapy With in Vitro Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy US 60/408,681 Abandoned
NCI E-035-2002-0-US-01 Backbone Substituted Bifunctional DOTA Ligands And Complexes thereofmbk US 60/408,676 Abandoned
NIDCR E-295-2001-0-PCT-02 Imaging The Activity of Extracellular Proteases In Cells Using Mutant Anthax Toxin Protective Antigens That Are Cleaved By Specific Extracellular Proteases. PCT PCT PCT/US02/028397 Expired
NCI E-239-2002-0-US-01 Minimally Immunogenic Variant of Humanized COL-I Antibody Against Carcinoembryonic Antigen (CEA) US 60/408,703 Abandoned
NCI E-082-2004-0-US-01 Methods of Preventing or Treating T Cell Malignancies by Administering CD2 Antagonists US 60/409,024 Abandoned
NCI E-245-2002-0-US-01 AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF US 60/407,239 Abandoned
NCI E-064-2001-0-US-02 Measurements of Multiple RNA, Proteins And Antibody Binding Using CryoArray US ORD 10/233,193 6951761 Expired PDF
NCI E-064-2001-0-PCT-03 MEASUREMENTS OF MULTIPLE MOLECULES USING A CRYOARRAY PCT PCT PCT/US2002/027955 Expired
NIMH E-247-2001-0-PCT-02 Effect of BDNF Genotype on verbal Memory And Risk For Schizophrenia PCT PCT PCT/US02/28086 Expired
NCI E-236-2001-0-PCT-02 New Adenovirus Type 7 Vectors PCT PCT PCT/US2002/027592 Expired
NCI E-335-2001-0-PCT-02 Methods of Generating Human CD4+ TH1 Cells PCT PCT PCT/US02/27824 Expired
NCI E-151-2002-0-PCT-02 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS PCT PCT PCT/US02/027297 Expired
NCI E-151-2002-0-EP-04 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS EP National Stage 02770437.8 Abandoned
NCI E-151-2002-0-CA-03 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS CA National Stage 2496802 Abandoned
NHLBI E-003-2000-0-US-03 Regulators of Type-1 Tumor Necrosis Factor Receptor and Other Cytokine Receptor Shedding US National Stage 10/220,443 7135303 Abandoned PDF
CC E-278-1999-0-US-04 Multiplex Hybridization System For The Identification Of Pathogenic Mycobacterium And Method Of Use US National Stage 10/220,212 7271781 Abandoned PDF
NCI E-151-2002-0-US-01 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS US ORD 10/229,316 6852842 Abandoned PDF
NIDCR E-320-2001-0-AU-06 METHODS OF INHIBITING FORMATION OF VASCULAR CHANNELS AND METHODS OF INHIBITING PROLIFERATION AU National Stage 2002323368 Abandoned
NCI E-150-2001-1-US-01 Use of a Promotor of T-Cell Expansion And an Inducer of CD40 Stimulation in The Treatment or Prevention of a Pathologic State US ORD 10/226,959 7175838 Abandoned PDF
NCI E-290-2000-0-JP-07 Detection And Quantification of Cripto-1 JP National Stage 2002-559686 Abandoned